Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 245

1.

BALL-SNPgp-from genetic variants toward computational diagnostics.

Mueller SC, Backes C, Gress A, Baumgarten N, Kalinina OV, Moll A, Kohlbacher O, Meese E, Keller A.

Bioinformatics. 2016 Feb 15. pii: btw084. [Epub ahead of print]

PMID:
27153685
2.

Identification of miR-34a-target interactions by a combined network based and experimental approach.

Hart M, Rheinheimer S, Leidinger P, Backes C, Menegatti J, Fehlmann T, Grässer F, Keller A, Meese E.

Oncotarget. 2016 Apr 29. doi: 10.18632/oncotarget.9103. [Epub ahead of print]

3.

miEAA: microRNA enrichment analysis and annotation.

Backes C, Khaleeq QT, Meese E, Keller A.

Nucleic Acids Res. 2016 Apr 29. pii: gkw345. [Epub ahead of print]

4.

Syntaxin 8 is required for efficient lytic granule trafficking in cytotoxic T lymphocytes.

Bhat SS, Friedmann KS, Knörck A, Hoxha C, Leidinger P, Backes C, Meese E, Keller A, Rettig J, Hoth M, Qu B, Schwarz EC.

Biochim Biophys Acta. 2016 Jul;1863(7 Pt A):1653-64. doi: 10.1016/j.bbamcr.2016.04.014. Epub 2016 Apr 17.

PMID:
27094127
5.

miRTargetLink-miRNAs, Genes and Interaction Networks.

Hamberg M, Backes C, Fehlmann T, Hart M, Meder B, Meese E, Keller A.

Int J Mol Sci. 2016 Apr 14;17(4). pii: E564. doi: 10.3390/ijms17040564.

6.

Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.

Ludwig N, Werner TV, Backes C, Trampert P, Gessler M, Keller A, Lenhof HP, Graf N, Meese E.

Int J Mol Sci. 2016 Mar 30;17(4). pii: E475. doi: 10.3390/ijms17040475.

7.

Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier.

Kuehn A, Kletting S, de Souza Carvalho-Wodarz C, Repnik U, Griffiths G, Fischer U, Meese E, Huwer H, Wirth D, May T, Schneider-Daum N, Lehr CM.

ALTEX. 2016 Mar 17. doi: 10.14573/altex.1511131. [Epub ahead of print]

8.

Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.

Tenzer S, Leidinger P, Backes C, Huwer H, Hildebrandt A, Lenhof HP, Wesse T, Franke A, Meese E, Keller A.

Oncotarget. 2016 Mar 22;7(12):14857-70. doi: 10.18632/oncotarget.7562.

9.

Distribution of miRNA expression across human tissues.

Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, Rheinheimer S, Meder B, Stähler C, Meese E, Keller A.

Nucleic Acids Res. 2016 May 5;44(8):3865-77. doi: 10.1093/nar/gkw116. Epub 2016 Feb 25.

10.

Deep characterization of blood cell miRNomes by NGS.

Schwarz EC, Backes C, Knörck A, Ludwig N, Leidinger P, Hoxha C, Schwär G, Grossmann T, Müller SC, Hart M, Haas J, Galata V, Müller I, Fehlmann T, Eichler H, Franke A, Meder B, Meese E, Hoth M, Keller A.

Cell Mol Life Sci. 2016 Feb 13. [Epub ahead of print]

PMID:
26874686
11.

Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.

Leidinger P, Hart M, Backes C, Rheinheimer S, Keck B, Wullich B, Keller A, Meese E.

Tumour Biol. 2016 Jan 29. [Epub ahead of print]

PMID:
26831660
12.

EDISON-WMW: Exact Dynamic Programing Solution of the Wilcoxon-Mann-Whitney Test.

Marx A, Backes C, Meese E, Lenhof HP, Keller A.

Genomics Proteomics Bioinformatics. 2016 Feb;14(1):55-61. doi: 10.1016/j.gpb.2015.11.004. Epub 2016 Jan 29.

13.

Validating Alzheimer's disease micro RNAs using next-generation sequencing.

Keller A, Backes C, Haas J, Leidinger P, Maetzler W, Deuschle C, Berg D, Ruschil C, Galata V, Ruprecht K, Stähler C, Würstle M, Sickert D, Gogol M, Meder B, Meese E.

Alzheimers Dement. 2016 May;12(5):565-76. doi: 10.1016/j.jalz.2015.12.012. Epub 2016 Jan 22.

PMID:
26806387
14.

Multi-omics enrichment analysis using the GeneTrail2 web service.

Stöckel D, Kehl T, Trampert P, Schneider L, Backes C, Ludwig N, Gerasch A, Kaufmann M, Gessler M, Graf N, Meese E, Keller A, Lenhof HP.

Bioinformatics. 2016 May 15;32(10):1502-8. doi: 10.1093/bioinformatics/btv770. Epub 2016 Jan 18.

PMID:
26787660
15.

Gene amplification during myogenic differentiation.

Fischer U, Ludwig N, Raslan A, Meier C, Meese E.

Oncotarget. 2016 Feb 9;7(6):6864-77. doi: 10.18632/oncotarget.6845.

16.

Bias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies.

Backes C, Sedaghat-Hamedani F, Frese K, Hart M, Ludwig N, Meder B, Meese E, Keller A.

Anal Chem. 2016 Feb 16;88(4):2088-95. doi: 10.1021/acs.analchem.5b03376. Epub 2016 Jan 27.

PMID:
26760198
17.

High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.

Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A.

Oncotarget. 2016 Jan 26;7(4):4611-23. doi: 10.18632/oncotarget.6566.

18.

Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings?

Keller A, Meese E.

Wiley Interdiscip Rev RNA. 2016 Mar;7(2):148-56. doi: 10.1002/wrna.1320. Epub 2015 Dec 15. Review.

19.

Prioritizing and selecting likely novel miRNAs from NGS data.

Backes C, Meder B, Hart M, Ludwig N, Leidinger P, Vogel B, Galata V, Roth P, Menegatti J, Grässer F, Ruprecht K, Kahraman M, Grossmann T, Haas J, Meese E, Keller A.

Nucleic Acids Res. 2016 Apr 7;44(6):e53. doi: 10.1093/nar/gkv1335. Epub 2015 Dec 3.

20.

Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.

Lerner C, Wemmert S, Bochen F, Kulas P, Linxweiler M, Hasenfus A, Heinzelmann J, Leidinger P, Backes C, Meese E, Urbschat S, Schick B.

J Cancer Res Clin Oncol. 2016 Apr;142(4):757-66. doi: 10.1007/s00432-015-2087-y. Epub 2015 Nov 30.

PMID:
26621153
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk